Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination.
about
Mechanisms of Cross-protection by Influenza Virus M2-based VaccinesThe role of Fc-FcγR interactions in IgG-mediated microbial neutralizationA Novel Vaccination Strategy Mediating the Induction of Lung-Resident Memory CD8 T Cells Confers Heterosubtypic Immunity against Future Pandemic Influenza VirusFc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design.Cross Protection against Influenza A Virus by Yeast-Expressed Heterologous Tandem Repeat M2 Extracellular Proteins.Co-immunization with tandem repeat heterologous M2 extracellular proteins overcomes strain-specific protection of split vaccine against influenza A virus.What Lies Beneath: Antibody Dependent Natural Killer Cell Activation by Antibodies to Internal Influenza Virus Proteins.Effects of MF59 Adjuvant on Induction of Isotype-Switched IgG Antibodies and Protection after Immunization with T-Dependent Influenza Virus Vaccine in the Absence of CD4+ T Cells.Antigen delivery by virus-like particles for immunotherapeutic vaccination.Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.M2-based influenza vaccines: recent advances and clinical potential.Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate.Cross-Protective Efficacy of Influenza Virus M2e Containing Virus-Like Particles Is Superior to Hemagglutinin Vaccines and Variable Depending on the Genetic Backgrounds of Mice.The Unexpected Impact of Vaccines on Secondary Bacterial Infections Following Influenza.Complement C3 Plays a Key Role in Inducing Humoral and Cellular Immune Responses to Influenza Virus Strain-Specific Hemagglutinin-Based or Cross-Protective M2 Extracellular Domain-Based Vaccination
P2860
Q26777740-5E78FE30-5F3D-4337-8450-EC2E51B9045AQ26797466-B16D9C1E-CB09-4B04-805D-C298A340709DQ30384304-0ADFD077-96CE-44D0-A874-E1579BB6641EQ30400230-40F8F778-A24F-4383-8A44-80BD6B0A7286Q35772241-52408E39-711F-4640-AE86-E8EC0DDA1542Q36030772-077EE217-0101-4F0F-8E00-52C1C8E507CAQ37034475-4B22E834-B466-4411-9882-5204AD7B0192Q37093487-F77E7B66-7010-4E99-8EB6-94888A3F3D51Q38285854-377A7547-CCDA-4451-BF81-C0CFC600216DQ40050261-EF55ECC7-CECD-4985-81FB-9AAEDEAEE520Q40571808-8F2F3F8B-AE75-4EBB-9364-A372603FD280Q45325239-667F3671-A3B0-4FD5-B11F-2C2286DEA79EQ47159626-537006BE-5350-4AB3-A424-29620738A66BQ47576940-2B2192DF-5E58-4FC0-AFB0-83703691B93AQ57469912-5F87AEC8-27EB-4882-B4F3-AFF6909B2992
P2860
Fc receptor is not required for inducing antibodies but plays a critical role in conferring protection after influenza M2 vaccination.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Fc receptor is not required fo ...... fter influenza M2 vaccination.
@en
Fc receptor is not required fo ...... fter influenza M2 vaccination.
@nl
type
label
Fc receptor is not required fo ...... fter influenza M2 vaccination.
@en
Fc receptor is not required fo ...... fter influenza M2 vaccination.
@nl
prefLabel
Fc receptor is not required fo ...... fter influenza M2 vaccination.
@en
Fc receptor is not required fo ...... fter influenza M2 vaccination.
@nl
P2093
P2860
P356
P1433
P1476
Fc receptor is not required fo ...... fter influenza M2 vaccination.
@en
P2093
Hye Suk Hwang
Jong Seok Lee
Ki-Hye Kim
Min-Chul Kim
Sang-Moo Kang
Young-Tae Lee
P2860
P304
P356
10.1111/IMM.12310
P577
2014-10-01T00:00:00Z